BOSTON — A lawsuit says representatives of some of the nation’s largest generic drug manufacturers used code words to collude with competitors to divvy up market share and coordinate price increases. The code came in emails included in the lawsuit filed last month by attorneys general from more than 40 states. The 510-page federal lawsuit
